|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Department of Thoracic and Cardiovascular Surgery (Drs. Korpela and Harjula), Helsinki University Central Hospital, Helsinki, Finland; Institute of Biotechnology (Dr. Sariola), Helsinki; Satakunta Central Hospital (Dr. Aarnio), Pori, Finland; and Institute of Biomaterials (Dr. Törmälä), Tampere University of Technology, Tampere, Finland.
| Abstract |
|---|
|
|
|---|
Key Words: airway stenosis airway stent bioabsorbable material poly-L-lactide
| Introduction |
|---|
|
|
|---|
Surgical resection and end-to-end anastomosis is the method of choice to handle airway stenosis, but this is not always possible due to the nature and cause of the stenosis and the general state of the patient. Tracheobronchial malacia is also difficult to correct surgically. Experiments have been performed in which tracheal prostheses or homografts have been substituted for the trachea. Endobronchial methods for handling airway stenoses have been developed, including laser surgery, cryotherapy, endobronchial resection, brachytherapy (in malignant obstructions), and dilatation and stenting of the stenotic area of the airway.3
The most common types of stents in use are made of silicone4 or metallic wire.5 Silicone stents are relatively thick, and these stents cause mucociliary function to be lost in the stented area and have a tendency for secretions to accumulate in their lumen, which can cause obstruction. Metallic stents, once they have been covered by the epithelium, can be removed by rigid bronchoscopy, but open surgery may be required. The ideal stent for tracheobronchial stenosis has yet to be designed, but Colt and Dumon6 have listed the requirements for such a stent.
Bioabsorbable airway stents could offer benefits that the stents now available for clinical use do not offer. Extraction of the stent would not be necessary, and resorption of the device would not interfere with the normal function of the airway. The time of absorption of the stent can be modified, depending on the choice of the basic molecule with which it is manufactured, the shape, the degree of polymerization, the internal arrangement of the material components, and the site of implantation. Bioabsorbable materials degrade and are metabolized to water and carbon dioxide by hydroxylation inside normal tissue. A very strong but elastic bioabsorbable stent can be designed; self-expanding models can be made. The biocompatibility of bioabsorbable materials has been good in other organs. Rods of bioabsorbable polyglycolic acid and polylactic acid are in clinical use for the fixation of bone fractures, with favorable results.7 SR-PLLA spiral stents have been shown to have good biocompatibility with the rabbit urethra.8 Spiral stents made of self-reinforced polyglycolic acid were used in the human urethra to prevent postoperative urinary retention after visual laser ablation, with good results.9
In this study, we examined the treatment of tracheal stenosis with three types of intratracheal stents in an animal model: the silicone tube, metallic tubular mesh, and an SR-PLLA spiral, which is a new material for stents. Poly-L-lactide was chosen for an absorbable bronchial stent because it has the longest biodegradation time of the basic molecules available.
| Materials and Methods |
|---|
|
|
|---|
Altogether, 32 rabbits underwent the first operation in which the arch of tracheal cartilage was partly excised in order to create a tracheal stenosis. One animal died before insertion of the stent, and another died during that procedure. Group A, using silicone stents, comprised 10 rabbits with a mean weight of 2.5 kg (range, 2.1 to 3.0 kg); group B, using SR-PLLA stents, comprised 11 rabbits with a mean weight of 2.7 kg (range, 2.2 to 3.5 kg); and group C, using metallic stents, comprised 9 rabbits with a mean weight of 2.7 kg (range, 2.1 to 3.0 kg).
The rabbits were anesthetized with atropine (0.75 mg/kg of body weight), ketamine (20 mg/kg of body weight), medetomide (300 µg/kg of body weight), and diazepam (1.0 mg/kg of body weight). Procaine penicillin (150,000 IU) was used as an antibiotic prophylaxis. All these drugs were administered subcutaneously. The animals maintained spontaneous breathing during the operation. The cervical trachea was prepared by sight through the midline incision, and three to five cartilage arches spanning an area half the circumference of the trachea were excised submucously; an area of about 5 x 8 mm was then without the support of the cartilage. The wound was closed in layers. After a follow-up period of 4 to 8 weeks, the rabbits were operated on again using the same anesthetic procedure. The area previously operated on was prepared by sight, and a transverse incision was made in the trachea that was about two thirds of its circumference and that was between cartilage distal to the stenosed area where the cartilage previously had been partly excised. A 6-mm thick angioplasty balloon catheter was inserted through the bronchotomy at the stenosed area, which was then dilatated by filling the balloon. The pressure of the balloon was regulated manually by visual inspection in order to avoid overdistension and extra damage to the bronchial wall. Then the stent was placed in the dilatated area, the bronchotomy was closed with an uninterrupted 50 polypropylene suture, and the wound was closed in layers. If the rabbits had stridor or difficulties with breathing during follow-up, they were killed. If they were doing well, they were put to death 3, 6, or 9 months postoperatively.
The stented area in the cervical trachea was excised for further investigation. The specimen was divided longitudinally into two pieces; one half was fixed in 4% formalin solution for histologic examination, and the other half was fixed in 2% buffered glutaraldehyde solution for scanning electron microscope (SEM) studies. From paraffin-embedded tissue specimens, 4-µm thick longitudinal sections were cut and stained with hematoxylin and eosin. The magnitude of the inflammation, the fibrosis, and the changes in the epithelium were assessed semiquantitatively as follows: 0 = normal; 1 = mild changes; 2 = moderate changes; and 3 = severe changes. Tissue samples for SEM studies were dehydrated in ethanol, were critical-point dried (Balzers CPD 020; Balzers Union Ltd; Vaduz, Liechtenstein), were mounted on aluminum studs, and were coated with gold with a sputtering device (model JFC-1100; Jeol Ltd; Tokyo, Japan). A digital SEM (model DSM 962; Carl Zeiss; Oberkochen, Germany) was used at a 10-kV acceleration voltage in SEM studies at the Electron Microscopy unit of the Institute of Biotechnology at the University of Helsinki. Changes in the epithelial cell layer and in ciliated cells were evaluated. Due to the nature of findings in histologic and SEM studies, quantitative analysis was not performed.
All animals received humane care in compliance with the "European Convention for Protection of Vertebrate Animals Used For Experimental and Other Scientific Purposes," ratified in Strasbourg in 1986 by the Council of Europe. The study protocol was approved by the institutional committee for test animal research.
| Results |
|---|
|
|
|---|
The follow-up time in group A ranged from 6 to 39 weeks (mean, 22 weeks); all animals in this group, except one, were put to death because of stridor and difficulties in breathing. Viewed macroscopically at autopsy, a light brown obstructive material was apparent inside the lumen of the stent, and mucosal hyperplasia had developed at the ends of the stents, which caused stenosis in the tracheal lumen.
In group B, the rabbits were followed for 13 to 39 weeks (mean, 24 weeks); one rabbit died of uncertain causes 24 weeks postimplantation. The stent had disappeared, but the lumen was well open; otherwise, the findings were unexceptional. Another rabbit died 31 weeks after surgery. In the lumen of the trachea, parts of the spirals of the stent were noticed; this disintegration of the stent may have caused the death of the rabbit. One rabbit was killed 26 weeks postoperatively because of stridor caused by parts of spirals of the stent occluding the lumen of the trachea. Findings at autopsy for the other seven rabbits were acceptable: two stents had disappeared, but each lumen was still open. In five animals, the stents were in place, the lumen was fully open, and stenosis had not developed again.
In group C, rabbits were followed for 13 to 38 weeks (mean, 25 weeks), and all were killed at the end of the follow-up period. At autopsy, all the stents were satisfactorily in place, partly covered by the growing epithelium, and the lumen was open with no stenosis having recurred.
For light microscopic studies, the stents had to be removed before the cutting of the paraffin-embedded tissue samples. Epithelial ulceration was noticed under the silicone stents as well as under the spirals of the SR-PLLA stents and under the filaments of the metallic stents (Fig 1 ). Masses of polypoid granulation tissue and moderate eosinophilia were noticed at the ends of the silicone stents, and moderate chronic lymphocytic inflammation also was noticed under the stents (Fig 2 ). In group B, reserve-cell hyperplasia was detected between the stent spirals; some degree of eosinophilia and chronic lymphocytic inflammation was apparent in the same areas. Between the metallic stent filaments there was reserve-cell hyperplasia, eosinophilia, and some degree of chronic lymphocytic inflammation. No foreign-body reaction occurred in any group; all stents were histologically well tolerated, although SR-PLLA and metallic stents seemed to cause somewhat less eosinophilia and chronic lymphocytic inflammation than stents made of silicone.
|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
Because of the poor prognosis of patients with malignant airway obstruction, palliative methods are needed to maintain airway patency. Bolliger et al13 used 38 Dumon stents in 31 patients for endoscopic palliation of malignant airway stenosis. Their patients underwent laser resection and insertion of the stent, followed by percutaneous or endobronchial radiotherapy. Complications were noticed with 10 stents, with migration being the most common. Both Dumon silicone stents and metallic stents, with or without a silicone covering, were used to treat patients with severe dyspnea for airway stenoses caused by malignant tumors. Bolliger et al13 concluded that stents play an important role in the improvement of respiratory symptoms and in the quality of life of patients with malignant tracheobronchial stenosis that was impossible to cure by surgery. Bare metallic stents are effective in extrinsic compression, but Dumon stents or covered metallic stents are preferable for use in intraluminal stenosis.14
Rousseau et al5 used 39 Wallstent and 35 Gianturco (Cook Europe; Bjaerverskov, Denmark) stents in 55 patients with 33 tracheal and 29 bronchial noninflammatory (except for one) lesions. The group using the Wallstent showed a total of six complications, with one tumoral proliferation successfully treated endoscopically with a laser. Gianturco stents were used exclusively for tracheobronchomalacia. In this group, Rousseau et al5 noticed a high rate (31%) of complications such as braces in the filament branches with or without migration of the stent that potentially can lead to obstruction or wall perforation. They summarized that Wallstent insertion is a safe procedure and a good alternative to silicone stent insertion for the treatment of post-transplantation bronchial stenoses without inflammatory lesions. Both silicone15 and self-expandable metallic stents5 ,16 thus have performed satisfactorily in the treatment of post-transplantation airway stenoses.
Extramucosal resection of the cartilaginous arches of the trachea in pigs has been used to create an experimental malacia.17 When Marquette et al18 resected three tracheal rings and, in addition, used caustic agent intrabronchially during rigid bronchoscopy to create a tracheal stenosis, the clinically significant tracheal stenosis developed in their adult mini-pigs in 8 weeks. We used almost the same method, but without any caustic agent to create an experimental cervical tracheal stenosis, in our rabbits in order to evaluate various possibilities for treating the stenosis with dilatation and different types of intratracheal stents.
In our study, the material of the stents was well tolerated, and no foreign-body reaction was noticed on histologic evaluation. The findings in histologic and SEM studies in the groups using metallic and SR-PLLA stents were so similar and the differences were so minor that no significant difference between these groups could be found. The changes in the group using silicone stents were more obvious. Clinically, silicone stents performed the worst. All rabbits in that group had to be killed due to respiratory symptoms. In the group using SR-PLLA stents, parts of the disintegrating spiral could have caused obstruction of the airways; one rabbit died spontaneously, and the other was killed because of respiratory symptoms. In the group using the Wallstent, no complications developed, and the animals could be followed to the end of the follow-up period. In SEM studies, a well-preserved carpet of ciliated cells was noticed in the stent material in the groups using SR-PLLA and metallic stents. Eight animals showed structural abnormality of the cilia, which were flattened. However, this can be an artifact, due to the fixation procedures for SEM studies. In a prospective study of intubated patients, Konrad et al19 found that impaired mucociliary transport in intubated patients is associated with the loss of cilia rather than with ultrastructural abnormalities of the cilia. We had no method to measure the mucociliary transport across the stents. The finding in SEM studies of well-preserved ciliary cells between the filaments of the stents in the groups using metallic and biosabsorbable stents suggests that mucociliary transport can work after the ciliated epithelium has covered the stents.
| Conclusion |
|---|
|
|
|---|
| Footnotes |
|---|
Correspondence to: Antti Korpela, MD, Department of Surgery, Päijät-Häme Central Hospital, Keskussairaalankatu 7, 15850 Lahti, Finland
Abbreviations: SEM = scanning electron microscope; SR-PLLA = self-reinforced poly-L-lactide
Received for publication May 21, 1997. Accepted for publication July 7, 1998.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. Noppen, G. Stratakos, J. D'Haese, M. Meysman, and W. Vinken Removal of Covered Self-Expandable Metallic Airway Stents in Benign Disorders: Indications, Technique, and Outcomes Chest, February 1, 2005; 127(2): 482 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ernst, D. Feller-Kopman, H. D. Becker, and A. C. Mehta Central Airway Obstruction Am. J. Respir. Crit. Care Med., June 15, 2004; 169(12): 1278 - 1297. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ernst, S. Kim, R. L. Gordon, and J. A. Golden Metal Stenting as First-Line Therapy for Tracheal Compression After Gastric Pull-up Chest, December 1, 2002; 122(6): 2269 - 2269. [Full Text] [PDF] |
||||
![]() |
Y. Saito, K. Minami, M. Kobayashi, Y. Nakao, H. Omiya, H. Imamura, N. Sakaida, and A. Okamura New tubular bioabsorbable knitted airway stent: Biocompatibility and mechanical strength J. Thorac. Cardiovasc. Surg., January 1, 2002; 123(1): 161 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ghaye and R.F. Dondelinger Imaging guided thoracic interventions Eur. Respir. J., March 1, 2001; 17(3): 507 - 528. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Robey, T. Valimaa, H. S. Murphy, P. Tormala, D. J. Mooney, and R. A. Weatherly Use of Internal Bioabsorbable PLGA "Finger-Type" Stents in a Rabbit Tracheal Reconstruction Model Arch Otolaryngol Head Neck Surg, August 1, 2000; 126(8): 985 - 991. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |